CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

AZD9793 Intravenous (IV) monotherapy

Phase 2
AstraZeneca PLC (AZN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
AZNPhase 2

AZD9793 Intravenous (IV) monotherapy Phase 2 Est. Readout

AZD9793 Intravenous (IV) monotherapy
Q2 2027~Q
CT.gov
00%
Competitive Landscape

2 competitors in Hepatocellular Carcinoma

View Full Landscape
Drug Information

Target Indication

Hepatocellular Carcinoma

Clinical Trial

NCT06795022

Last updated: 1/10/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.